U.S. Capital Markets Stock News

Two Harbors Investment (NYSE:TWO) is the subject of a takeover battle involving competing bids from UWM Holdings and CrossCountry Mortgage. The board of NYSE:TWO has rejected multiple acquisition attempts from UWM Holdings and is backing a fully financed, all-cash offer from CrossCountry Mortgage. The contest now centers on a shareholder vote, proxy solicitations, and competing arguments about value, deal structure, and execution risk. For you as a NYSE:TWO shareholder, this is not a...

Wondering if Ally Financial at around US$43 per share still offers value, or if most of the easy gains are behind it, starts with understanding what the current price is actually reflecting. The stock has had mixed recent returns, with a 2.7% decline over the last week, an 8.5% gain over the last month, a 5.6% decline year to date, and a 36.8% return over the last year alongside an 88.9% three year return and a 2.9% five year decline. Recent coverage has focused on how Ally Financial fits...

Avista’s Q1 2026 earnings in focus Avista (AVA) has rolled into Q1 2026 on the back of a solid run through 2025, capped by Q4 revenue of US$533 million and basic EPS of US$0.87, alongside trailing 12 month EPS of US$2.38 on US$1.96 billion of revenue. Over recent quarters, the company has seen revenue hold in a US$394 million to US$617 million range while quarterly EPS moved between US$0.17 and US$0.98. The trailing net profit margin is 9.8% compared with 9.3% a year earlier, which puts the...

In the past quarter, Adaptive Biotechnologies reported first‑quarter 2026 revenue of US$70.87 million, up from US$52.44 million a year earlier, while narrowing its net loss to US$20.03 million and reducing basic loss per share from US$0.20 to US$0.13. The results were powered by Minimal Residual Disease testing, with clonoSEQ volumes rising strongly and management raising full‑year 2026 MRD revenue guidance to US$260–US$270 million, underscoring the segment’s growing importance to the...

AGCO (AGCO) has just opened Q1 2026 earnings season with recent quarterly numbers that plot a sharp swing in profitability, moving from a Q4 2024 net loss of US$255.7 million on US$2,887.3 million of revenue and EPS of US$3.43 loss, to Q4 2025 net income of US$95.5 million on US$2,920.2 million of revenue and EPS of US$1.29. Over the same period, trailing twelve month EPS shifted from a US$5.69 loss on US$11.7 billion of revenue to US$9.76 on US$10.1 billion. Revenue moved from US$2,599.3...

In late April 2026, Opera Limited reported past first-quarter 2026 results showing sales of US$175.77 million and net income of US$24.79 million, alongside higher basic and diluted EPS of US$0.27 from continuing operations. On the same day, Opera raised its full-year 2026 revenue outlook to US$727 million–US$740 million and projected robust double-digit year-over-year growth for both the second quarter and the full year, highlighting management’s confidence in the business. With Opera...

Investors may be wondering if ConocoPhillips at around US$123.32 still offers value after a strong run, or if recent enthusiasm has already been priced in. The stock has seen a 27.5% return year to date and 45.5% over the last year, even though the last 7 days and 30 days showed returns of a 0.8% decline and a 5.5% decline, respectively. Recent coverage has focused on ConocoPhillips as a major integrated energy producer, with attention on how it is positioning its portfolio and capital...

Pinnacle Financial Partners, Inc. has already reported first‑quarter 2026 results, with net income rising to US$150 million from US$140 million a year earlier, while basic and diluted earnings per share from continuing operations fell to US$0.89 from about US$1.78 and US$1.77, respectively. This combination of higher total profit but sharply lower per‑share earnings, alongside AI-driven trading showing mixed time‑horizon sentiment, adds complexity to how investors may interpret Pinnacle’s...

AnaptysBio recently reported that the Delaware Chancery Court dismissed Tesaro’s anticipatory breach of contract claim over their Jemperli collaboration, while CEO Daniel Faga is set to discuss the company’s royalty assets at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. This legal outcome, combined with a stronger earnings outlook highlighted by an upgraded Zacks rank, strengthens AnaptysBio’s position around its Jemperli-related royalty rights. We’ll now...

In the first quarter of 2026, Molson Coors Beverage Company reported year-on-year increases in sales to US$2,717.9 million, revenue to US$2,351.1 million, and net income to US$151.3 million, with basic earnings per share from continuing operations rising to US$0.80. The company coupled these stronger results with a three-year US$450 million cost-savings program, continued integration of Monaco Cocktails, and reaffirmed full-year 2026 guidance despite ongoing volume and cost pressures. We’ll...

AGNC Investment (AGNC) opened 2026 with a softer quarter, reporting Q1 total revenue of a loss of US$114 million and a basic EPS loss of US$0.17, set against trailing twelve month revenue of US$1.6 billion and EPS of US$1.22. Over recent periods the company has seen quarterly revenue move from US$154 million in Q4 2024 to US$995 million in Q4 2025, with basic EPS shifting from US$0.10 to US$0.83 over the same span. Trailing twelve month revenue rose from US$973 million in Q4 2024 to US$1.8...

Alphatec Holdings (ATEC) is back in focus after reporting first quarter 2026 results, with a net loss of US$33.91 million and basic loss per share of US$0.22 from continuing operations. See our latest analysis for Alphatec Holdings. At a share price of US$10.23, Alphatec Holdings has seen a 9.41% 7 day share price return but a 50.72% year to date share price decline. The 1 year total shareholder return is 15.94% lower, suggesting recent momentum has faded despite interest around the Q1 2026...

In late April 2026, The Scotts Miracle-Gro Company reported past second-quarter results showing US$1,459.5 million in sales and US$238.6 million in net income, with both basic and diluted earnings per share from continuing operations increasing year over year. Alongside these results, Scotts Miracle-Gro reaffirmed its fiscal 2026 outlook and outlined its SMG 2.0 plan targeting meaningful growth, higher margins, lower leverage, and a multi-year share repurchase program that together could...

Wondering whether Scotts Miracle-Gro at around US$60.06 is priced for a recovery or still carrying too much risk? This article focuses on what the current share price might be implying about value. The stock has been volatile recently, with a 7 day return of an 8.1% decline, a 30 day return of a 6.0% decline, and a 1 year return of 14.3%, while the 5 year return sits at a 70.3% decline. Recent headlines around Scotts Miracle-Gro have focused on the company’s position in consumer lawn and...

Why Erie Indemnity’s latest earnings and dividend matter for shareholders Erie Indemnity (ERIE) reported first quarter earnings with revenue of US$1,011.91 million and net income of US$150.47 million, alongside an approved US$1.4625 quarterly dividend per Class A share. See our latest analysis for Erie Indemnity. Erie Indemnity’s recent earnings and dividend news comes after a challenging spell for the stock, with a 30 day share price return of an 11.33% decline and a year to date share price...

The Bank of N.T. Butterfield & Son (NTB) has drawn fresh attention after first quarter results showed higher net interest income, net income and earnings per share, along with a reaffirmed dividend and completed share buyback. See our latest analysis for Bank of N.T. Butterfield & Son. The share price sits at $55.81 after a 1-day share price return of 1.92%, building on a 30-day share price return of 4.38% and a year to date share price return of 12.29%. The 1-year total shareholder return of...

Elevance Health (NYSE:ELV) is rolling out nationwide mental health access and early intervention programs through community partnerships and digital tools. The Elevance Health Foundation currently has $23 million in active grants focused on mental health initiatives across the United States. These efforts aim to connect members with earlier, community-based care that complements the company’s existing clinical programs. For investors watching NYSE:ELV, this push into broader mental health...

In the first quarter of 2026, Transocean Ltd. reported net income of US$71 million on US$1.08 billion of revenue, turning around from a loss a year earlier while also expanding its contract backlog to about US$7.10 billion. The company’s strong rig uptime, higher average dayrates, and US$1.6 billion of new long-term contracts in regions such as Norway, Brazil, and the Eastern Mediterranean highlight how operational improvements are translating into firmer multi-year revenue visibility. With...

This article examines whether Cohen & Steers at US$69.54 is offering fair value and breaks down what the current price may be indicating about the stock. The share price is up 0.9% over the last week and 11.0% over the past month. Year to date it is up 9.4%, while the 1 year return stands at a 6.4% decline, set against a 3 year return of 42.2% and a 5 year return of 17.1%. Recent headlines have focused on Cohen & Steers in the context of the wider Capital Markets sector, with attention on...

In March 2026, ImmunityBio received an FDA warning letter over allegedly misleading promotional claims for its bladder cancer drug Anktiva, triggering multiple securities class action lawsuits that allege misrepresentation and securities fraud. At the same time, the company has reported very large year-over-year product revenue growth and accelerating global adoption of Anktiva, creating a tension between operational momentum and heightened legal and regulatory risk. We’ll now examine how...

IAC (IAC) has just posted its Q1 2026 scorecard, and the latest trailing twelve month figures show total revenue of about US$2.4 billion with a basic EPS loss of US$1.49 and net income excluding extra items of US$119.31 million in losses. Over recent quarters the company has seen quarterly revenue move from US$642 million in Q3 2024 to US$721.44 million in Q4 2024, then to US$570.49 million in Q1 2025 and US$645.98 million in Q4 2025. Basic EPS shifted from a loss of US$3.40 in Q3 2024 to a...

Viper Energy Q1 2026 earnings snapshot Viper Energy (VNOM) opened Q1 2026 with mixed signals, as trailing twelve month revenue sat at US$1.3 billion against a loss of US$69 million, translating into trailing EPS of US$0.48. The most recent quarterly print in Q4 2025 showed revenue of US$411 million and a net loss of US$103 million, or EPS of US$0.61. Over the past few reported quarters, revenue has moved from US$232 million in Q1 2025 to US$283 million in Q2 2025, US$399 million in Q3 2025...

In April 2026, Daily Racing Form, a subsidiary of Affinity Interactive, announced multi-year exclusive print distribution agreements with American Wagering and Boyd Gaming, making it the sole provider of racing publications across key Las Vegas casinos including Boyd’s Gold Coast, Orleans and Sam’s Town properties. The tie-up deepens Boyd Gaming’s connection to core racing customers ahead of marquee events such as the Kentucky Derby, while aligning with Apex Hospitality’s broader push to...

Investors may be wondering whether Oppenheimer Holdings at around US$99 a share still offers value, or if most of the opportunity has already been priced in. The stock has been volatile recently, with an 11.3% pullback over the last 7 days alongside a 9.3% gain over 30 days, and returns of 36.8% year to date and 69.4% over the past year. Recent headlines around capital markets activity and trading conditions have kept investor attention on brokers and financial services stocks, including...